U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 481 - 490 of 983

Criminal Justice DrugFacts

This NIDA web page includes facts and figures on addressing substance use disorders in the prison population.
Format
Web Page
Audience
States
Policymakers and Payers
Other Team Members
Communities
Source
National Institute on Drug Abuse (NIDA)
Year
Resource Type
Web Page

Ensuring appropriate quality, access, and utilization of digital therapeutics (PDF - 189 KB)

This worksheet provides recommendations for patients, clinicians, and payors, on how to ensure digital therapeutic quality, access, and utilization when considering mental health apps, including those for substance use.
Format
Fact Sheet/Brochure
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Source
Digital Therapeutics Alliance (DTA)
Year
Resource Type
PDF

FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency (PDF - 201 KB)

SAMHSA recognizes the challenges posed by the current COVID-19 situation and is providing the following guidance on the provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency for Opioid Treatment Programs.
Format
Fact Sheet/Brochure
Audience
Medical Providers
Behavioral Health Providers
States
Source
Substance Abuse and Mental Health Services Administration
Year
Resource Type
PDF

Framing Opioid Prescribing Guidelines for Acute Pain (PDF - 7.8 MB)

This guideline develops a framework to evaluate existing clinical practice guidelines for prescribing opioids for acute pain indications and recommends indications for which new evidence-based guidelines should be developed.
Format
Guide
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
The National Academies of Sciences, Engineering, and Medicine
Year
Resource Type
PDF

Getting Paid for MAT: Sustainable Reimbursement Series

This webinar series includes resources and trainings related to administering and reimbursement for medications for addiction treatment, including reimbursement for telehealth for substance use disorders.

Format
Webinar/Video
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Organizational Leadership
Source
University of California, Los Angeles (UCLA) Integrated Subtance Abuse Programs; Pacific Southwest Addiction Technology Transfer Center (ATTC)
Year
Resource Type
Web Page

How Practices Can Advance the Implementation of Integrated Care in the COVID-19 Era (PDF - 295 KB)

This issue brief presents a literature review of primary care practices implementing integrated behavioral health care which identified the main barriers to successful integration as financing, health information technology, and workforce challenges.

Format
Report/Paper/Issue Brief
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Policymakers and Payers
Source
Docherty M, et al.; The Commonwealth Fund
Year
Resource Type
PDF

How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency (PDF - 141 KB)

These policies are effective beginning March 31, 2020, and will remain in effect for the duration of the public health emergency, unless DEA specifies an earlier date. This decision tree summarizes policies adopted in response to the COVID-19 public health emergency by the Drug Enforcement Administration (DEA) to allow DEA-registered practitioners to prescribe controlled substances without having to interact in-person with their patients the policies. This decision tree is for quick reference and does not provide a complete description of all requirements.
Format
Other
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Drug Enforcement Administration (DEA)
Year
Resource Type
PDF